# HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

Study · id `cardio:ct-nct02073565` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02073565](<https://clinicaltrials.gov/study/NCT02073565>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02073565

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 572 participants.

## Technical summary

Registry record NCT02073565. Randomized; single masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2017-07-14 (actual). Results posted on 2018-11-21.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 572 participants (enrolled count; ClinicalTrials.gov record NCT02073565, source copy `cardio:ctgov-nct02073565-2022-05-13`, retrieved 2026-10-26)
- Start date: 2014-02 (registry gives no type) (ClinicalTrials.gov record NCT02073565, source copy `cardio:ctgov-nct02073565-2022-05-13`, retrieved 2026-10-26)
- Primary completion: 2017-07-14 (actual) (ClinicalTrials.gov record NCT02073565, source copy `cardio:ctgov-nct02073565-2022-05-13`, retrieved 2026-10-26)
- Completion: 2021-12 (actual) (ClinicalTrials.gov record NCT02073565, source copy `cardio:ctgov-nct02073565-2022-05-13`, retrieved 2026-10-26)
- Results first posted: 2018-11-21 (ClinicalTrials.gov record NCT02073565, source copy `cardio:ctgov-nct02073565-2022-05-13`, retrieved 2026-10-26)
- Countries: United States; Japan (ClinicalTrials.gov record NCT02073565, source copy `cardio:ctgov-nct02073565-2022-05-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02073565-2022-05-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
- Acronym: HARMONEE
- Condition: Coronary Arteriosclerosis
- Condition: Non ST Segment Elevation Acute Coronary Syndrome
- Intervention (Device): OrbusNeich Combo stent™
- Intervention (Device): Everolimus Eluting Stent (EES)
- Lead sponsor: OrbusNeich
- Lead sponsor class: INDUSTRY
- Collaborator: OrbusNeich Medical K.K.
- Collaborator class: UNKNOWN
- Collaborator: Duke Clinical Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: OrbusNeich (`cardio:org-orbusneich`)
- Registry lists this organization as a collaborator: Duke Clinical Research Institute (`cardio:org-duke-clinical-research-institute`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome (`cardio:pubmed-29931092`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5fbd73af01a0afc4bbeb066a3765262c95a994f1d1b048f64bd8d9114741d52d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
